Literature DB >> 1558791

Enhancing effect of partial gastrectomy on pancreatic carcinogenesis.

P Watanapa1, B Flaks, H Oztas, P H Deprez, J Calam, R C Williamson.   

Abstract

The controversial issue of enhanced pancreatic carcinogenesis following partial gastrectomy has been explored in male Wistar rats (n = 40) weighing 250-300 g. Animals were randomised to receive either 60% distal gastrectomy with Roux-en-Y reconstruction or gastrotomy and resuture (control). Immediately after operation each group was further divided into two subgroups, receiving i.p. injections of either saline or azaserine (30 mg kg-1 wk-1 for 3 weeks). At 15 months blood was obtained at 0, 5, 15 and 30 min after a fatty meal for cholecystokinin (CCK) assay; rats were then killed. Pancreatic wet weight was measured, and histological sections were examined for atypical acinar cell foci (AACF), the putative precursor lesion of carcinoma. There were no significant differences in body weight or pancreatic weight between controls and rats with gastrectomy. Only azaserine-treated rats had acidophilic AACF. Partial gastrectomy substantially increased the number of acidophilic AACF per pancreas (median 26.05 vs 2.09; P less than 0.005), with a 9-fold increase in their volume (P less than 0.005). Basal and postprandial plasma CCK concentrations were higher after gastrectomy than in controls (P less than 0.05). Partial gastrectomy has an enhancing effect on azaserine-induced pancreatic carcinogenesis, probably by means of increased CCK release.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1558791      PMCID: PMC1977619          DOI: 10.1038/bjc.1992.77

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  31 in total

1.  Dietary habits and past medical history as related to fatal pancreas cancer risk among Adventists.

Authors:  P K Mills; W L Beeson; D E Abbey; G E Fraser; R L Phillips
Journal:  Cancer       Date:  1988-06-15       Impact factor: 6.860

2.  Influence of cholecystokinin antagonist on the effects of cholecystokinin and bombesin on azaserine-induced lesions in rat pancreas.

Authors:  B R Douglas; R A Woutersen; J B Jansen; A J de Jong; L C Rovati; C B Lamers
Journal:  Gastroenterology       Date:  1989-02       Impact factor: 22.682

3.  Adenocarcinoma of the pancreas in azaserine-treated rats.

Authors:  D S Longnecker; T J Curphey
Journal:  Cancer Res       Date:  1975-08       Impact factor: 12.701

4.  Effect of partial gastrectomy with Billroth II or Roux-en-Y anastomosis on postprandial and cholecystokinin-stimulated gallbladder contraction and secretion of cholecystokinin and pancreatic polypeptide.

Authors:  P N Rieu; J B Jansen; W P Hopman; H J Joosten; C B Lamers
Journal:  Dig Dis Sci       Date:  1990-09       Impact factor: 3.199

5.  Aging and the trophic effects of cholecystokinin, bombesin and pentagastrin on the rat pancreas.

Authors:  G J Poston; R Saydjari; J P Lawrence; D Chung; C M Townsend; J C Thompson
Journal:  Pancreas       Date:  1991-07       Impact factor: 3.327

6.  Gastric emptying of liquid meals and pancreatic and biliary secretion after subtotal gastrectomy or truncal vagotomy and pyloroplasty in man.

Authors:  I MacGregor; J Parent; J H Meyer
Journal:  Gastroenterology       Date:  1977-02       Impact factor: 22.682

7.  Late mortality after surgery for peptic ulcer.

Authors:  A H Ross; M A Smith; J R Anderson; W P Small
Journal:  N Engl J Med       Date:  1982-08-26       Impact factor: 91.245

8.  Pancreatic polypeptide. Metabolism and effect on pancreatic secretion in dogs.

Authors:  I L Taylor; T E Solomon; J H Walsh; M I Grossman
Journal:  Gastroenterology       Date:  1979-03       Impact factor: 22.682

9.  Effect of duodenogastric reflux on gastric mucosal proliferation after gastric surgery.

Authors:  P W Houghton; N J Mortensen; R C Williamson
Journal:  Br J Surg       Date:  1987-04       Impact factor: 6.939

10.  Mucosal changes in the gastric stump 20-25 years after partial gastrectomy.

Authors:  E Schrumpf; A Serck-Hanssen; J Stadaas; S Aune; J Myren; M Osnes
Journal:  Lancet       Date:  1977-09-03       Impact factor: 79.321

View more
  7 in total

1.  Resection of the gastric fundus in rats.

Authors:  R C Williamson; P Watanapa
Journal:  Gut       Date:  1994-01       Impact factor: 23.059

Review 2.  On the role of cholecystokinin in pancreatic cancer.

Authors:  M K Herrington; T E Adrian
Journal:  Int J Pancreatol       Date:  1995-04

3.  Duodenogastric reflux and pancreatic growth.

Authors:  R C Williamson; P Watanapa
Journal:  Gut       Date:  1995-06       Impact factor: 23.059

4.  Pancreatic cancer after remote peptic ulcer surgery.

Authors:  M Tascilar; B P van Rees; P D J Sturm; G N J Tytgat; R H Hruban; S N Goodman; F M Giardiello; G J A Offerhaus; A C Tersmette
Journal:  J Clin Pathol       Date:  2002-05       Impact factor: 3.411

5.  Synchronous or metachronous double cancers of the pancreas and other organs: report on 12 cases.

Authors:  N Eriguchi; S Aoyagi; M Hara; K Okuda; T Tamae; S Fukuda; K Hashino; S Sato; K Fujiki; S Furukawa; A Jimi
Journal:  Surg Today       Date:  2000       Impact factor: 2.549

6.  Synchronous double cancers of the remnant stomach and pancreas: report of a case.

Authors:  T Miyaguni; Y Muto; T Kusano; M Yamada; M Matsumoto; M Shiraishi
Journal:  Surg Today       Date:  1995       Impact factor: 2.549

7.  The effect of intermittent injections of CCK-8S and the CCK-A receptor antagonist devazepide on cell proliferation in exocrine rat pancreas.

Authors:  B Ohlsson; K Borg; J F Rehfeld; I Ihse; J Axelson
Journal:  Int J Pancreatol       Date:  1998-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.